Bottom line
GTHIX vs SHSSX: the short answer
GTHIX (INVESCO Health Care Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds.
SHSSX is cheaper at 0.86% vs 1.07% — a difference of $21 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +3.7% for GTHIX.
Updated Nov 19, 2026
GTHIX vs SHSSX side by side
| GTHIX | SHSSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.07% | 0.86% |
| Annual cost per $10k | $107 | $86 |
| 10-yr cost on $10k (prospectus) | $1,306 | $1,061 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +15.5% | +16.3% |
| 5-yr return (annualized) | +3.7% | +5.9% |
| 10-yr return (annualized) | +6.4% | +9.8% |
| Best quarter | +19.6% | — |
| Worst quarter | −16.5% | — |
| Net assets (fund) | $1.2B | $5.9B |
| Number of holdings | 82 | 155 |
| Portfolio turnover | 59% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of GTHIX's top 25 holdings also appear in SHSSX's top 25.
| Holding | GTHIX | SHSSX |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 12.29% |
| Johnson & Johnson | 6.76% | 8.77% |
| UnitedHealth Group Inc. | 6.17% | 6.10% |
| Merck & Co., Inc. | 4.59% | 4.94% |
| AbbVie Inc. | 4.03% | 3.94% |
| Gilead Sciences, Inc. | 3.63% | 4.19% |
| argenx SE | 3.24% | 1.26% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.74% |
| Edwards Lifesciences Corp. | 1.56% | 2.51% |
| Thermo Fisher Scientific Inc. | 1.55% | 3.02% |
Source: SEC Form N-PORT
GTHIX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between GTHIX and SHSSX?
GTHIX (INVESCO Health Care Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds. SHSSX is cheaper at 0.86% vs 1.07% — a difference of $21 a year per $10,000 invested.
Which is cheaper, GTHIX or SHSSX?
SHSSX has the lower expense ratio (0.86%).
Should I own both GTHIX and SHSSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.